关于互换血型试剂的欧洲协议

技术法规类型:欧盟Eurlex法规 来源:tbtmap

EURLEX ID:21987A0207(04)

OJ编号:OJ L 37, 7.2.1987, p. 31-32

中文标题:关于互换血型试剂的欧洲协议

原文标题:European Agreement on the Exchange of Blood-grouping Reagents

分类:02.70_国际海关合作;11.30.30_多边海关合作

文件类型:外部关系 Agreement, opinion|协议、意见

生效日期:1987-04-01

废止日期:2058-12-31

法规全文:查看欧盟官方文件

EUR-Lex - 21987A0207(04) - EN
| EUROPA > EUR-Lex > ID celex

21987A0207(04)


Title and reference

European Agreement on the Exchange of Blood-grouping Reagents

OJ L 37, 7.2.1987, p. 31‘�2 (ES, DA, DE, EL, EN, FR, IT, NL, PT)
Finnish special edition: Chapter 11 Volume 11 P. 0376
Swedish special edition: Chapter 11 Volume 11 P. 0376
CS.ES Chapter 02 Volume 02 P. 251
ET.ES Chapter 02 Volume 02 P. 251
HU.ES Chapter 02 Volume 02 P. 251
LT.ES Chapter 02 Volume 02 P. 251
LV.ES Chapter 02 Volume 02 P. 251
MT.ES Chapter 02 Volume 02 P. 251
PL.ES Chapter 02 Volume 02 P. 251
SK.ES Chapter 02 Volume 02 P. 251
SL.ES Chapter 02 Volume 02 P. 251

Text

BG ES CS DA DE ET EL EN FR GA IT LV LT HU MT NL PL PT RO SK SL FI SV
html html html html html html html html html html html html html html html html html html html
pdf pdf pdf pdf pdf pdf pdf pdf pdf pdf pdf

Authentic language

  • English, French

Dates

    of document: 26/01/1987
    of effect: 01/04/1987; Entry into force See Art 8
    of signature: 30/03/1987; Strasbourg
    end of validity: 99/99/9999; See Art. 11

Classifications

Miscellaneous information

  • Author:
    European Economic Community, The 12 Member States, Cyprus, Liechtenstein, Malta, Norway, Sweden, Switzerland, Turkey
  • Form:
    Agreement
  • INDEX.CM:
  • Depositary:
    Council of Europe - Secretary-General
  • Additional information:
    Validity : notice of termination of 1 Year

Relationship between documents

Text

Bilingual display: BG CS DA DE EN ES ET FI FR HU IT LT LV MT NL PL PT RO SK SL SV

EUROPEAN AGREEMENT on the Exchange of Blood-grouping Reagents

THE SIGNATORY GOVERNMENTS OF THE MEMBER STATES OF THE COUNCIL OF EUROPE,

Considering that blood-grouping reagents are not available in unlimited quantities;

Considering that it is most desirable that member countries, in a spirit of European solidarity, should assist one another in the supply of these blood-grouping reagents, should the need arise;

Considering that such mutual assistance is only possible if the character and use of such blood-grouping reagents are subject to rules laid down jointly by the member countries and if the necessary import facilities and exemptions are granted,

HAVE AGREED AS FOLLOWS:

Article 1

For the purposes of this Agreement, the expression "blood-grouping reagents" refers to reagents of human, animal and plant and other origin, used for blood-grouping and for the detection of blood incompatibilities.

Any Contracting Party may, by a declaration addressed to the Secretary-General of the Council of Europe, when signing this Agreement or depositing its instrument of ratification or approval, or accession, limit the application of this Agreement to blood-grouping reagents of human origin. This declaration may be withdrawn at any time, by notification addressed to the Secretary-General of the Council of Europe.

Article 2

The Contracting Parties undertake, provided that they have sufficient stocks for their own needs, to make blood-grouping reagents available to other Parties who are in urgent need of them and to charge only those costs of collection, processing and carriage of such substances and the cost (if any) of their purchase.

Article 3

Blood-grouping reagents shall be made available to the other Contracting Parties subject to the condition that no profit is made on them, that they shall be used solely for medical purposes and shall be delivered only to bodies designated by the Government concerned.

Article 4

The Contracting Parties shall certify that the provisions as laid down in the Protocol to this Agreement have been observed.

They shall also comply with any rules to which they have subscribed with regard to international standardization in this field.

All consignments of blood-grouping reagents shall be accompanied by a certificate to the effect that they were prepared in accordance with the specifications in the Protocol. This certificate shall be based on the model to be found in the Annex to the Protocol.

The Protocol and its Annex constitute an administrative arrangement and may be amended or supplemented by the Governments of the Parties to this Agreement.

Article 5

The Contracting Parties shall take all necessary measures to exempt from all import duties the blood-grouping reagents placed at their disposal by the other Parties.

They shall also take all necessary measures to provide for the speedy delivery of these substances, by the most direct route, to the consignees referred to in Article 3 of this Agreement.

Article 6

The Contracting Parties shall forward to one another, through the Secretary-General of the Council of Europe, a list of the bodies empowered to issue certificates as provided in Article 4 of this Agreement.

They shall also forward a list of bodies empowered to distribute imported blood-grouping reagents. Wherever possible these bodies should be the same as those referred to in Article 6 of the European Agreement on the Exchange of Therapeutic Substances of Human Origin.

Article 7

The present Agreement shall be open to the signature of Members of the Council of Europe, who may become Parties to it either by: (a) signature without reservation in respect of ratification or approval ; or

(b) signature with reservation in respect of ratification or approval, followed by ratification or approval.

Instruments of ratification or approval shall be deposited with the Secretary-General of the Council of Europe.

Article 8

The present Agreement shall enter into force one month after the date on which three Members of the Council shall, in accordance with Article 7, have signed the Agreement without reservation in respect of ratification or approval or shall have ratified or approved it.

In the case of any Member of the Council who shall subsequently sign the Agreement without reservation in respect of ratification or approval or who shall ratify or approve it, the Agreement shall enter into force one month after the date of such signature or the date of deposit of the instrument of ratification or approval.

Article 9

After the entry into force of this Agreement, the Committee of Ministers of the Council of Europe may invite any non-member State to accede to the present Agreement. Such accession shall take effect one month after the date of deposit of the instrument of accession with the Secretary-General of the Council of Europe.

Article 10

The Secretary-General of the Council of Europe shall notify Members of the Council and acceding States: (a) of the date of entry into force of this Agreement and of the names of any Members who have signed without reservation in respect of ratification or approval or who have ratified or approved it;

(b) of the deposit of any instrument of accession in accordance with Article 9;

(c) of any declaration or notification received in accordance with the provisions of Article 1, paragraph 2;

(d) of any notification received in accordance with Article 11 and its effective date;

(e) of any amendment of the Protocol and of its Annex under Article 4, paragraph 4.

Article 11

The present Agreement shall remain in force indefinitely.

Any Contracting Party may terminate its own application of the Agreement by giving one year's notice to that effect to the Secretary-General of the Council of Europe.

In witness whereof the undersigned, duly authorized thereto by their respective Governments, have signed the present Agreement.

Done at Strasbourg, this 14th day of May 1962, in English and French, both texts being equally authoritative, in a single copy which shall remain deposited in the archives of the Council of Europe. The Secretary-General shall transmit certified copies to each of the signatory and acceding Governments.

Top

托管标准,您可以接收以下服务:

1 标准定期系统查新,若有最新版本,会以站内短信或邮件的形式通知用户;

2 随时在标准托管页面中查看到该条标准的最新状态;

3 若用户有在学习和科研中的需要,可以在标准托管页面中试阅标准;

4 企业如果需要上新产品,我院及时提供标准查询、采购等方面的支持;

5 为企业在标准制修订、企业良好行为创建以及标准化试点过程中遇到的困难,可联系我院指定相关专家负责进行指导帮助、提供政策咨询;

6 为企业提供标准化政策的解读、标准化知识的推广培训、标准自我公开声明、标准文献的免费查询、企业标准化体系建设等方面的标准化服务;

进入企业标准托管

您可以通过编辑查新模板,批量查询指定标准集的最新情况。我们会通过查询,向您展示您所查询标准的:

1. 准确的标准号及标准名称(我们通过人工智能技术对您提交的标准号进行自动纠正)

2. 标准的最新状态(现行、废止或未发布)

3. 若标准已废止并被新标准替代,会反馈被替代的标准

4. 若您已托管此标准,便可以实时跟踪这个标准的最新状态

标准查新 模板下载

您可以在这里检索全球超过140万条标准,支持上百个国内国际标准组织的标准查询。您也可以在这里检索国内各类国家、部委和地方的法律法规。

更多标准子库在持续建设中。

标准检索

标准资讯点击排行榜 全部

资讯标题点击

[[ n.title ]] [[ n.read ]]

大连标准化公共服务平台

版权:大连标准化研究院有限公司

地址:大连市中山区高原街56号

电话:0411-82740851

大连标准